In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

A study of almost 13,000 adults with Type 2 diabetes and high systolic blood pressure assessed if a more intensive treatment ...

Guang Ning, M.D., Ph.D., lead study author, elected member of the Chinese Academy of Engineering and professor at Ruijin Hospital at Shanghai Jiao Tong University School of Medicine in Shanghai, China ...